The major global manufacturers of Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market include: Airdoc Technology, Digital Diagnostics, Eyenuk, RetinaLyze System, Optomed, Sibionics Technology, Aeye Health, VUNO, Medimaging Integrated Solution, EyRIS (SELENA+), Vistel, RETINA-AI Health, Acer Medical.

The Global “Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market” Research Report 2024 offers a comprehensive analysis of the market, including its size, share, trends, growth opportunities, and potential for expansion. The report segments the market by value and volume, focusing on manufacturing, application, type, and geography. It provides a geographic analysis covering regions such as North America, Europe, Asia-Pacific, and the Rest of the World. Additionally, the Diabetic Retinopathy (DR) Artificial Intelligence Screening System market within each region is further segmented by major countries, including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Analysis and Insights:

Diabetic retinopathy (DR) represents a major cause of visual impairment in developed countries. The ever-growing incidence of DR and its complications necessitates new strategies to screen patients, prevent complications and optimize management. For this reason, DR is a major target of AI-based models, especially those that can be used for large-scale screening. AI models should recognize DR-related alterations, such as haemorrhages, exudates, cotton wool spots and neovascularization; and, starting from fundus images, establish the presence or absence of DR, and grade it according to the conventional DR grading scales.
The global Diabetic Retinopathy (DR) Artificial Intelligence Screening System market was valued at USD 86.8 million in 2023 and is anticipated to reach USD 6767 million by 2030, witnessing a CAGR of 84.8% during the forecast period 2024-2030.
Diabetes continues to rise throughout the United States and worldwide. Estimates show that the prevalence of diabetes mellitus will rise to 578 million people (10.2%) by the year 2030 and 700 million people (10.9%) by the year 2045. This increase in the prevalence of diabetes can also lead to a corresponding increase in diabetic complications, including nephropathy, cardiovascular disease, neuropathy, and retinopathy.
This report aims to provide a comprehensive presentation of the global market for Diabetic Retinopathy (DR) Artificial Intelligence Screening System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Retinopathy (DR) Artificial Intelligence Screening System.
The Diabetic Retinopathy (DR) Artificial Intelligence Screening System market size, estimations, and forecasts are provided in terms of and revenue (USD millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetic Retinopathy (DR) Artificial Intelligence Screening System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetic Retinopathy (DR) Artificial Intelligence Screening System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Airdoc Technology
Digital Diagnostics
Eyenuk
RetinaLyze System
Optomed
Sibionics Technology
Aeye Health
VUNO
Medimaging Integrated Solution
EyRIS (SELENA+)
Vistel
RETINA-AI Health
Acer Medical
Segment by Type
Hardware
Software
Segment by Application
Medical Institutions
Great Health Scene
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Diabetic Retinopathy (DR) Artificial Intelligence Screening System manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers.

Some of the players in the research report include:

  • Airdoc Technology
  • Digital Diagnostics
  • Eyenuk
  • RetinaLyze System
  • Optomed
  • Sibionics Technology
  • Aeye Health
  • VUNO
  • Medimaging Integrated Solution
  • EyRIS (SELENA+)
  • Vistel
  • RETINA-AI Health
  • Acer Medical

Inquire or Share Your Questions If Any Before the Purchasing This Report – https://www.absolutereports.com/enquiry/pre-order-enquiry/27877083

Diabetic Retinopathy (DR) Artificial Intelligence Screening System segment by Type:

  • Hardware
  • Software

Diabetic Retinopathy (DR) Artificial Intelligence Screening System segment by Application:

  • Medical Institutions
  • Great Health Scene

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2031.

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France

To Understand How Covid-19 Impact Is Covered in This Report – https://absolutereports.com/enquiry/request-covid19/27877083

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Diabetic Retinopathy (DR) Artificial Intelligence Screening System market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diabetic Retinopathy (DR) Artificial Intelligence Screening System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Diabetic Retinopathy (DR) Artificial Intelligence Screening System and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Diabetic Retinopathy (DR) Artificial Intelligence Screening System industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diabetic Retinopathy (DR) Artificial Intelligence Screening System.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapters included in this report:

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Diabetic Retinopathy (DR) Artificial Intelligence Screening System manufacturers competitive landscape, price, output and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Diabetic Retinopathy (DR) Artificial Intelligence Screening System by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Diabetic Retinopathy (DR) Artificial Intelligence Screening System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 5: Provides the analysis of various market segments according to product type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, revenue, , price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Analysis of sales channel, distributors and customers
  • Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

More.

Purchase this Report (Price 2900 USD for a Single-User License) – https://absolutereports.com/purchase/27877083

Detailed TOC of Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Research Report

1 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Overview

1.1 Product Definition

1.2 Diabetic Retinopathy (DR) Artificial Intelligence Screening System by Type

1.2.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Value Comparison by Type (2024-2030)

1.3 Diabetic Retinopathy (DR) Artificial Intelligence Screening System by Application

1.3.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Value by Application (2024-2030)

1.4 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Estimates and Forecasts

1.4.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue 2019-2030

1.4.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Sales 2019-2030

1.4.3 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Competition by Manufacturers

2.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Sales Market Share by Manufacturers (2019-2024)

2.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Diabetic Retinopathy (DR) Artificial Intelligence Screening System, Industry Ranking, 2024 VS 2023 VS 2024

2.5 Global Key Manufacturers of Diabetic Retinopathy (DR) Artificial Intelligence Screening System, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Diabetic Retinopathy (DR) Artificial Intelligence Screening System, Product Type & Application

2.7 Global Key Manufacturers of Diabetic Retinopathy (DR) Artificial Intelligence Screening System, Date of Enter into This Industry

2.8 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Competitive Situation and Trends

2.8.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Diabetic Retinopathy (DR) Artificial Intelligence Screening System Players Market Share by Revenue

2.8.3 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Scenario by Region

3.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Sales by Region: 2019-2030

3.2.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Sales by Region: 2019-2024

3.2.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Sales by Region: 2025-2030

3.3 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue by Region: 2019-2030

3.3.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue by Region: 2019-2024

3.3.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue by Region: 2025-2030

3.4 North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Facts & Figures by Country

3.4.1 North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Sales by Country (2019-2030)

3.4.3 North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Facts & Figures by Country

3.5.1 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Sales by Country (2019-2030)

3.5.3 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Facts & Figures by Region

3.6.1 Asia Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Sales by Region (2019-2030)

3.6.3 Asia Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Facts & Figures by Country

3.7.1 Latin America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Sales by Country (2019-2030)

3.7.3 Latin America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Facts & Figures by Country

3.8.1 Middle East and Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Sales by Country (2019-2030)

3.8.3 Middle East and Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Sales by Type (2019-2030)

4.1.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Sales by Type (2019-2024)

4.1.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Sales by Type (2025-2030)

4.1.3 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Sales Market Share by Type (2019-2030)

4.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue by Type (2019-2030)

4.2.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue by Type (2019-2024)

4.2.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue by Type (2025-2030)

4.2.3 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue Market Share by Type (2019-2030)

4.3 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Price by Type (2019-2030)

5 Segment by Application

5.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Sales by Application (2019-2030)

5.1.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Sales by Application (2019-2024)

5.1.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Sales by Application (2025-2030)

5.1.3 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Sales Market Share by Application (2019-2030)

5.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue by Application (2019-2030)

5.2.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue by Application (2019-2024)

5.2.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue by Application (2025-2030)

5.2.3 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue Market Share by Application (2019-2030)

5.3 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Manufacture 1

6.1.1 Manufacture 1 Company Information

6.1.2 Manufacture 1 Description and Business Overview

6.1.3 Manufacture 1 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Manufacture 1 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product Portfolio

6.1.5 Manufacture 1 Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Industry Chain Analysis

7.2 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Production Mode & Process

7.4 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Sales and Marketing

7.4.1 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Sales Channels

7.4.2 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Distributors

7.5 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Customers

8 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Dynamics

8.1 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Industry Trends

8.2 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Drivers

8.3 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Challenges

8.4 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

Contact Us:

Absolute Reports

Phone: US +1 (888) 690-5999

UK +44 8083 023308

Web: https://www.absolutereports.com

Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]